Form D · Other Health Care
Turek Labs INC
San Francisco, CA · CIK 0001731103
Offering snapshot reported Jun 19, 2018 · SEC filing
- Reported sold
- $125 Offering amount: $125
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $125 Reported outside-investor minimum
- First sale
- Jun 12, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2018 | Initial | $125 | No comparison | 1 | SEC filing |
| May 22, 2018 | Initial | $1,375 | No comparison | 3 | SEC filing |
| May 22, 2018 | Amendment | $1,375 | $0vs May 22, 2018 | 3 | SEC filing |
| Feb 13, 2018 | Initial | $50,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-314835
Source: Form D, filed Jun 19, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eduardo Dolhun | Director, Executive |
| Paul Turek | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
55 Francisco Street, Suite 300
San Francisco, CA, 94133
San Francisco, CA, 94133